Environmental, Social And Governance Report

Overview

The report describes Alphamab Oncology's 2022 ESG governance, environmental performance and social initiatives. It reports 11,462.82 tonnes of Scope 1 and Scope 2 greenhouse gas emissions, alongside reductions in energy, water and emissions intensity. The company employed 472 regular full-time employees and reported zero work-related fatalities. It also donated 120,000 ENWEIDA vials through its patient relief project and supported local pandemic response with 600 N95 masks.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services